Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Pediatric Blood and Marrow Transplant Consortium
St. Baldrick's Foundation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Information provided by (Responsible Party):
Center for International Blood and Marrow Transplant Research
ClinicalTrials.gov Identifier:
NCT01385787
First received: June 28, 2011
Last updated: September 3, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2018
  Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)